Characteristic | Prescribed Medication, % (n = Eligible Patients) | ||||
---|---|---|---|---|---|
Aspirin (n = 10,296) | B-blocker (n = 13,148) | ACE-I/ARB (n = 10,367) | Lipid lowering (n = 12,949) | All Meds (n = 8,267) | |
All eligible patients | 58.3 | 70.2 | 60.3 | 64.8 | 25.0 |
Age (yrs) | |||||
< 55 | 58.0 | 65.6 | 54.3 | 61.5 | 23.5 |
55-65 | 59.3 | 70.3 | 60.4 | 66.8 | 28.3 |
65-75 | 56.2 | 73.9 | 64.6 | 69.2 | 25.7 |
≥ 75 | 59.0 | 68.8 | 58.9 | 61.2 | 21.3 |
Female | 57.6 | 67.3 | 60.5 | 63.3 | 20.2 |
Ethnicity | |||||
White | 60.1 | 71.7 | 60.9 | 66.2 | 26.1 |
Non-white | 60.9 | 69.3 | 63.6 | 62.8 | 25.7 |
Unknown | 53.5 | 67.7 | 57.3 | 63.0 | 22.6 |
Socioeconomic status | |||||
Low | 57.2 | 70.3 | 60.8 | 63.9 | 24.4 |
Middle | 62.1 | 70.9 | 60.3 | 65.0 | 26.5 |
High | 50.9 | 67.3 | 57.4 | 68.0 | 22.5 |
Current smoker | 56.3 | 66.4 | 55.9 | 63.0 | 23.8 |
CABG | 63.3 | 79.1 | 66.5 | 75.0 | 32.8 |
PCI | 65.3 | 77.2 | 65.4 | 72.9 | 32.4 |
Hypertension | 59.1 | 72.1 | 64.4 | 66.7 | 26.6 |
Hyperlipidemia | 59.7 | 72.7 | 62.6 | 70.6 | 27.4 |
Diabetes | 62.4 | 76.3 | 70.7 | 68.8 | 29.8 |
Heart failure | 61.9 | 76.8 | 70.0 | 67.3 | 30.9 |
Cerebral vascular disease | 59.1 | 71.2 | 63.3 | 66.0 | 24.5 |
Peripheral vascular disease | 61.1 | 73.4 | 64.3 | 67.5 | 25.9 |
Chronic kidney disease | 59.2 | 76.4 | 60.9 | 67.5 | 27.4 |
COPD | 57.7 | 67.2 | 59.7 | 63.5 | 22.7 |